NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Thanks for reminding me that Juno and Kite had full results but no approval before buyout. They had me too therapies along with Novartis' Car-T therapy. Near term prospects in B-cell cancer at the time. Fraction of the 10% of oncology market. Still Far-off-term potential in solid tumor cancer. No shortcuts. Juno and Kite sold for about 10 billion each. Highly Cost prohibitive product for patients and/or insurers.